Ignite Creation Date:
2024-05-05 @ 12:05 PM
Last Modification Date:
2024-10-26 @ 9:19 AM
Study NCT ID:
NCT00232999
Status:
COMPLETED
Last Update Posted:
2021-11-12
First Post:
2005-10-04
Brief Title:
EfficacySafety Study of Nebulized IVX-0142 a Novel Antiallergic Drug in Mild Allergic Asthma
Sponsor:
Organization:
Teva Branded Pharmaceutical Products RD Inc